Middle meningeal artery embolization following burr hole in chronic subdural hematoma

Arham, Abrar; Zaragita, Nadya

doi:10.4103/ajns.ajns_15_20

Cited by 4 publications

(3 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Arham et al was the only author reporting MMAE application at the time of the first surgery as conjoint treatment with surgery. [3] Of note, none of the MMAE procedures were done concurrently with or before the surgical intervention. All procedures were done either solely or after surgical evacuation of the cSDHs was done.…”

Section: Resultsmentioning

confidence: 99%

Middle meningeal artery embolisation: The review of a new treatment for chronic subdural hematomas

Msheik

Fares

Mohanna

et al. 2023

Surgical Neurology International

View full text Add to dashboard Cite

Background: This is a literature review aiming to provide an update about the recent findings related to the efficacy of middle meningeal artery embolization (MMAE) in the treatment of chronic subdural hematomas (cSDHs), comparison with conventional therapy and deduction of the current recommendations and indications. Methods: The literature is reviewed using a search through the PubMed index using keywords. Studies are then screened, skimmed, and thoroughly read. 32 studies fulfilled the inclusion criteria and are included in the study. Results: Five indications for the application of MMA embolization (MMAE) are deducted from the literature. The usage as a preventive measure after surgical treatment of symptomatic cSDHs in patients with a high risk of recurrence and the usage as a standalone procedure has been the most common reasons for indication of this procedure. Rates of failures for the aforementioned indications have been 6.8% and 3.8%, respectively. Conclusion: The safety of MMAE as a procedure is regarded as a general theme in the literature and can be considered for future applications. Usage of this procedure in clinical trials with more patient segregation and timeframe assessment relative to surgical intervention are recommendations of this literature review.

show abstract

Section: Resultsmentioning

confidence: 99%

Middle meningeal artery embolisation: The review of a new treatment for chronic subdural hematomas

Msheik

Fares

Mohanna

et al. 2023

Surgical Neurology International

View full text Add to dashboard Cite

show abstract

“…From the analysis of the literature, we identified four indications for MMA embolization: To prevent surgery in patients with paucisymptomatic CSDHs,[ 7 , 9 , 13 - 15 , 19 , 20 , 24 , 35 - 37 , 48 , 50 , 51 ] As prophylaxis of a recurrence after a first surgery,[ 5 , 7 , 9 , 14 , 19 , 24 , 34 - 37 , 41 , 42 , 50 ] After a first recurrence to prevent further recurrence,[ 9 , 13 , 17 - 21 , 23 , 24 , 28 , 37 , 43 , 48 , 51 , 54 ] As an adjunctive treatment in case of a second surgery. [ 10 , 17 , 25 , 26 , 28 , 33 , 47 ] …”

Section: Discussionmentioning

confidence: 99%

“…As prophylaxis of a recurrence after a first surgery,[ 5 , 7 , 9 , 14 , 19 , 24 , 34 - 37 , 41 , 42 , 50 ]…”

Section: Discussionmentioning

confidence: 99%

Middle meningeal artery embolization for chronic subdural hematomas. A systematic review of the literature focused on indications, technical aspects, and future possible perspectives

Cristofori

Remida

Patassini

et al. 2022

Surgical Neurology International

View full text Add to dashboard Cite

Background: Chronic subdural hematoma (CSDH) is one of the most common neurosurgical diseases that affect elderly and fragile patients and as a consequence, management can be challenging. Surgery represents the standard treatment; however, alternative options are under investigation. Middle meningeal artery (MMA) embolization is considered a minimally invasive treatment although with poor evidence. In this review, we tried to summarize the findings about MMA embolization as a treatment for a CSDH to provide a useful guidance for clinical practice and for future speculative aspects. Methods: Literature review on PubMed until March 2021 was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement. We conducted a research on PubMed with a various combinations of the keywords “CSDH” and “middle meningeal artery” and “embolization,” “refractory subdural hematoma,” and then we reviewed the references of the relevant studies as additional source of eligible articles. Results: Among the 35 studies eligible for this review, 22 were case series, 11 were case reports, one was a technical note, and 1 was a randomized trial. A total of 746 patients were found in the literature. Failure rate of MMA embolization was between 3.9 and 8.9% of the cases according the indication to treat CSDH (upfront vs. after surgery). Conclusion: The global impression deriving from the data available and the literature is that MMA embolization is a safe procedure with very low complications and with a low failure rate, both when associated with surgery or in case of a standalone treatment.

show abstract

Middle Meningeal Artery Embolization in the Management of Chronic Subdural Hematoma: a Comprehensive Review of Current Literature

Désir

Narayan

Ellis

et al. 2023

Curr Neurol Neurosci Rep

View full text Add to dashboard Cite

Middle meningeal artery embolization following burr hole in chronic subdural hematoma

Cited by 4 publications

References 10 publications

Middle meningeal artery embolisation: The review of a new treatment for chronic subdural hematomas

Middle meningeal artery embolisation: The review of a new treatment for chronic subdural hematomas

Middle meningeal artery embolization for chronic subdural hematomas. A systematic review of the literature focused on indications, technical aspects, and future possible perspectives

Middle Meningeal Artery Embolization in the Management of Chronic Subdural Hematoma: a Comprehensive Review of Current Literature

Contact Info

Product

Resources

About